Cargando…

Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)

In response to the need of more rigorous data on medical cannabis and chronic pain, we conducted a 3-month prospective study incorporating ecological momentary assessment (EMA) to examine the effects of medical cannabis on pain, anxiety/depression, sleep, and quality of life. Data were collected fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Jacques, Jennifer Jean, Li, Zhigang, Sibille, Kimberly T., Cook, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Society on Marijuana 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525881/
https://www.ncbi.nlm.nih.gov/pubmed/34671723
http://dx.doi.org/10.26828/cannabis/2021.02.006
_version_ 1784585772892946432
author Wang, Yan
Jacques, Jennifer Jean
Li, Zhigang
Sibille, Kimberly T.
Cook, Robert L.
author_facet Wang, Yan
Jacques, Jennifer Jean
Li, Zhigang
Sibille, Kimberly T.
Cook, Robert L.
author_sort Wang, Yan
collection PubMed
description In response to the need of more rigorous data on medical cannabis and chronic pain, we conducted a 3-month prospective study incorporating ecological momentary assessment (EMA) to examine the effects of medical cannabis on pain, anxiety/depression, sleep, and quality of life. Data were collected from 46 adults (Mean age=55.7±11.9, 52.2% male) newly initiating medical cannabis treatment for chronic pain. Participants completed a baseline survey, EMA for approximately 1 week pre- and up to 3 weeks post-medical cannabis treatment, and a 3-month follow-up survey. The self-reported EMA data (2535 random and 705 daily assessments) indicated significant reductions in momentary pain intensity (b = -16.5, p < .001, 16.5 points reduction on 0-100 visual analog) and anxiety (b = -0.89, p < .05), and significant increase in daily sleep duration (b = 0.34, p < .01) and sleep quality (b = 0.32, p <.001) after participants initiated medical cannabis for a few weeks. At 3 months, self-reported survey data showed significantly lower levels of worst pain (t = -2.38, p < .05), pain interference (t = -3.82, p < .05), and depression (t = -3.43, p < .01), as well as increased sleep duration (t = 3.95, p < .001), sleep quality (t = -3.04, p < .01), and quality of life (t = 4.48, p < .001) compared to baseline. In our sample of primarily middle-aged and older adults with chronic pain, medical cannabis was associated with reduced pain intensity/inference, lower anxiety/depression, and improved sleep and quality of life.
format Online
Article
Text
id pubmed-8525881
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Research Society on Marijuana
record_format MEDLINE/PubMed
spelling pubmed-85258812021-10-19 Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA) Wang, Yan Jacques, Jennifer Jean Li, Zhigang Sibille, Kimberly T. Cook, Robert L. Cannabis Research Article In response to the need of more rigorous data on medical cannabis and chronic pain, we conducted a 3-month prospective study incorporating ecological momentary assessment (EMA) to examine the effects of medical cannabis on pain, anxiety/depression, sleep, and quality of life. Data were collected from 46 adults (Mean age=55.7±11.9, 52.2% male) newly initiating medical cannabis treatment for chronic pain. Participants completed a baseline survey, EMA for approximately 1 week pre- and up to 3 weeks post-medical cannabis treatment, and a 3-month follow-up survey. The self-reported EMA data (2535 random and 705 daily assessments) indicated significant reductions in momentary pain intensity (b = -16.5, p < .001, 16.5 points reduction on 0-100 visual analog) and anxiety (b = -0.89, p < .05), and significant increase in daily sleep duration (b = 0.34, p < .01) and sleep quality (b = 0.32, p <.001) after participants initiated medical cannabis for a few weeks. At 3 months, self-reported survey data showed significantly lower levels of worst pain (t = -2.38, p < .05), pain interference (t = -3.82, p < .05), and depression (t = -3.43, p < .01), as well as increased sleep duration (t = 3.95, p < .001), sleep quality (t = -3.04, p < .01), and quality of life (t = 4.48, p < .001) compared to baseline. In our sample of primarily middle-aged and older adults with chronic pain, medical cannabis was associated with reduced pain intensity/inference, lower anxiety/depression, and improved sleep and quality of life. Research Society on Marijuana 2021-10-01 /pmc/articles/PMC8525881/ /pubmed/34671723 http://dx.doi.org/10.26828/cannabis/2021.02.006 Text en © 2021 Authors et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits unrestricted use, distribution, and reproduction, provided the original author and source are credited, the original sources is not modified, and the source is not used for commercial purposes.
spellingShingle Research Article
Wang, Yan
Jacques, Jennifer Jean
Li, Zhigang
Sibille, Kimberly T.
Cook, Robert L.
Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)
title Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)
title_full Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)
title_fullStr Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)
title_full_unstemmed Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)
title_short Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA)
title_sort health outcomes among adults initiating medical cannabis for chronic pain: a 3-month prospective study incorporating ecological momentary assessment (ema)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525881/
https://www.ncbi.nlm.nih.gov/pubmed/34671723
http://dx.doi.org/10.26828/cannabis/2021.02.006
work_keys_str_mv AT wangyan healthoutcomesamongadultsinitiatingmedicalcannabisforchronicpaina3monthprospectivestudyincorporatingecologicalmomentaryassessmentema
AT jacquesjenniferjean healthoutcomesamongadultsinitiatingmedicalcannabisforchronicpaina3monthprospectivestudyincorporatingecologicalmomentaryassessmentema
AT lizhigang healthoutcomesamongadultsinitiatingmedicalcannabisforchronicpaina3monthprospectivestudyincorporatingecologicalmomentaryassessmentema
AT sibillekimberlyt healthoutcomesamongadultsinitiatingmedicalcannabisforchronicpaina3monthprospectivestudyincorporatingecologicalmomentaryassessmentema
AT cookrobertl healthoutcomesamongadultsinitiatingmedicalcannabisforchronicpaina3monthprospectivestudyincorporatingecologicalmomentaryassessmentema